The National Pharmaceutical Pricing Authority (NPPA) has so far fixed ceiling prices for 890 scheduled formulations and retail prices for around 2,023 new drugs, among others, said the minister of state for chemicals and fertilizers, Bhagwanth Khuba.

In a written reply in Lok Sabha, he said that the NPPA has fixed the ceiling prices of 890 scheduled formulations across various therapeutic categories under the National List of Essential Medicines (NLEM) 2015 and the retail prices of 2,023 new drugs under the Drug (Prices Control) Order, 2013.

Click for more on NPPA

The maximum retail price of 106 non-scheduled drug formulations was capped, including that for 22 diabetic and 84 cardiovascular drugs. Ceiling prices of orthopedic knee implants were fixed under Para 19 of DPCO, 2013.

The trade margin of non-scheduled formulations of 42 select anti-cancer medicines was capped under the ‘Trade Margin Rationalization’ approach as a pilot for proof of concept.

The NPPA has also regulated the prices of oxygen concentrators, pulse oximeters, blood pressure monitoring machines, nebulizers, digital thermometers, and glucometers under the ‘Trade Margin Rationalization" Approach.

Click for more on DPCO 2013

The National List of Essential Medicines (NLEM) notified by the Ministry of Health & Family Welfare consists of essential medicines falling under various therapeutic categories. 

The Minister said that these medicines are incorporated in the First Schedule of the DPCO, 2013 and their ceiling prices are fixed by NPPA as per the provisions of DPCO, 2013.

Latest on National Pharmaceutical Pricing Authority (NPPA)

Latest notifications – DPCO / NPPA

Latest Notifications: EC Act (Essential Commodities Act)

FAQs – On DPCO: Drugs (Prices Control) Order, 2013

‘No provision’ to absorb Ukraine Medical returnees

USFDA issues Form 483 for 3 observations to Biocon for Telangana plant

Drug Regulators give preliminary nod for Monkeypox vaccine

Govt is set to fix trade margins of long-term-use drugs

Govt launches three schemes for Pharma Industry

USFDA gives nod for this Blood Pressure injection

NMC directs State Medical Councils to take action against Quacks

FDA Haryana team raided, Codeine syrup recovered, FIR lodged

Dostarlimab: A wonder new drug ? shown positive results in a Clinical Trial

Latest Notifications regarding Pharmaceuticals
https://thehealthmaster.com/2022/07/23/nppa-fixed-ceiling-prices-of-890-formulations-and-retail-price-of-2023-new-drugs-govt/